Literature DB >> 22449367

Myeloproliferative neoplasms.

Julie Kim1, Rami Y Haddad, Ehab Atallah.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449367     DOI: 10.1016/j.disamonth.2012.01.002

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  4 in total

Review 1.  The Role of MicroRNAs in Myeloproliferative Neoplasia.

Authors:  Shaban Alizadeh; Seyed Ghader Azizi; Masoud Soleimani; Yadollah Farshi; Zahra Kashani Khatib
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-07-01

2.  Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated.

Authors:  Nicolás Martínez-Calle; Marien Pascual; Raquel Ordoñez; Edurne San José Enériz; Marta Kulis; Estíbaliz Miranda; Elisabeth Guruceaga; Víctor Segura; María José Larráyoz; Beatriz Bellosillo; María José Calasanz; Carles Besses; José Rifón; José I Martín-Subero; Xabier Agirre; Felipe Prosper
Journal:  Haematologica       Date:  2019-01-17       Impact factor: 9.941

3.  Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice.

Authors:  Kaiyao Shi; Wanke Zhao; Yun Chen; Wanting Tina Ho; Ping Yang; Zhizhuang Joe Zhao
Journal:  J Hematol Oncol       Date:  2014-03-19       Impact factor: 17.388

4.  Correlation analysis between JAK2, MPL, and CALR mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics.

Authors:  Tao Lang; Yuling Nie; Zengsheng Wang; Qin Huang; Li An; Yichun Wang; Guzailinuer Wufuer; Aziguli Maimaiti; Ling Fu; Yan Li; Xiaoyan Zhang; Aihemaitijiang Aisimutula; Xiaomin Wang; Lin Zhu; Hong Liu; Min Mao
Journal:  J Int Med Res       Date:  2018-08-07       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.